The use of antiovulatory contraceptive pills has increased rapidly in recent years and the World Health Organisation estimates that they are being taken by more than 20 million women throughout the world. In Britain, the Committee on the Safety of Drugs has stated that contraceptive pills are employed by over a million and a half women at the present time. The increasing use of these preparations has been followed by a corresponding increase in the number of side-effects attributed to them; some have been serious and a number of deaths have been reported. This paper presents further information about the relationship between gestogenic contraceptive pills and vaginal candidosis. Although this is usually a benign complication, it may lead to distressing symptoms, and on rare occasions to serious systemic manifestations. The condition can be passed to men at sexual intercourse, when it usually results in balanoposthitis.
Candida albicans is a facultative pathogen. Its pathogenicity depends not only on the size of the colonies, but also on the tolerance of the host tissues to it. There is evidence that the mucosa of the mouth, intestines, and vagina can show a marked tolerance to the fungus, whereas it is probable that it usually causes symptoms when found on the skin or elsewhere (Kozinn and Taschdjian, 1966) . A change in the tissues or the metabolism of the host may disturb the equilibrium and lead to the development of symptoms.
There is general agreement that the incidence of vaginal candidosis is increasing in many countries and the condition is being diagnosed more frequently (Pumpianski and Sheskin, 1965 trichomonal vaginitis to cases of vaginal candidosis was two to one amongst all the women complaining of genital symptoms and three to one amongst those complaining specifically of vaginal discharge. By 1969 the ratios had changed completely, so that for all the women with genital symptoms the ratio was one to three and for those complaining of vaginal discharge it was one to two (Table I) . Many of the commoner conditions which favour the development of Candida albicans in the vagina are well known (Table II) . In Britain, the most important are pregnancy, diabetes mellitus, antibiotic therapy, steroid therapy, and the use of antitrichomonal agents. Evidence that gestogenic pills play an important role in the recent increase in incidence of vaginal candidosis has been put forward by a number of authors. Bourg (1964) observed that six of sixty patients taking contraceptive pills developed vaginal candidosis. Gardner (1965) stated that half his patients with vaginal candidosis were using these preparations and thought that the recent increase in the incidence of the condition was almost entirely due to antiovulatory contraceptives. Walsh, Hildebrandt, and Prystowsky (1965) demonstrated Candida in twenty-two of twenty-four patients using contraceptive pills and Yaffee and Grots (1965) found that they could cure their patients of vaginal candidosis only by discontinuing the pills. Porter and Lyle (1966) treated thirteen patients with candidosis, who were using oral contraceptive pills; most of them required two or three courses of nystatin to clear the condition and in three cases it was necessary to discontinue the pills before cure could be achieved.
Catterall (1966) described six women whose symptoms first appeared about 9 months after starting to take contraceptive pills. He also described four men who presented with balanoposthitis due to Candida albicans; all of their sexual partners were found to have vaginal candidosis and had been taking pills for 6 to 12 months. These findings were confirmed by Rieth (1967) , who described penile symptoms after coitus in a man whose partner was found to have vaginal candidosis and had been taking pills for 10 months.
However, Morris and Morris (1967, 1969 ) were unable to demonstrate a relationship between oral contraceptives and the incidence of Candida albicans in the vagina or any other change in the vaginal flora. Gardner (1965) (Wynn and Doar, 1969) . They were unable to predict which women were likely to develop serious impairment of glucose tolerance and could only speculate whether the impaired glucose tolerance and raised plasma insulin levels might increase the rate of development of clinical diabetes mellitus and of atherosclerosis. Spellacy (1969) reviewed the evidence of impaired oral and intravenous glucose tolerance and the changes in the circulating levels of other compounds related to glucose tolerance, including insulin, non-esterified fatty acid, and pyruvate.
An analysis of the records of 200 women attending James Pringle House at the Middlesex Hospital and found to have vaginal candidosis, showed that 99 were taking contraceptive pills, 22 had recently been prescribed broad-spectrum antibiotics, twelve were pregnant, and ten had taken a course of antitrichomonal agents, shortly before the diagnosis of candidosis was made. Two patients were found to have diabetes. No cause could be found for the condition in 55 patients (Table III) 
